Genome sequence of E. coli O104:H4 leads to rapid development of a targeted antimicrobial agent against this emerging pathogen (scientific article (publication date: 2012))

Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC)

Q24624844

Retargeting R-type pyocins to generate novel bactericidal protein complexes

Q24647143

Crystal structure of Escherichia coli phage HK620 tailspike: podoviral tailspike endoglycosidase modules are evolutionarily related

Q27650795

Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany

Q28244221

Escherichia coli O157.

Q33392428

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany

Q33395886

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study

Q33395933

German outbreak of Escherichia coli O104:H4 associated with sprouts

Q33397821

The pyocins of Pseudomonas aeruginosa

Q33962385

How do bacteria resist human antimicrobial peptides?

Q34575973

Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis

Q36145701

Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model

Q36593833

Shiga toxin-producing Escherichia coli (STEC).

Q37761776

An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal disease

Q39658992

Pyocin R1 inhibits active transport in Pseudomonas aeruginosa and depolarizes membrane potential

Q39967811

Genomic medicine has failed the poor

Q40308703

Use of pyocin 78-C2 in the treatment of Pseudomonas aeruginosa infection in mice

Q40730532

Enterohemorrhagic Escherichia coli O157:H7 gal mutants are sensitive to bacteriophage P1 and defective in intestinal colonization

Q42248495

An engineered R-type pyocin is a highly specific and sensitive bactericidal agent for the food-borne pathogen Escherichia coli O157:H7.

Q43102717

Three-component-mediated serotype conversion in Pseudomonas aeruginosa by bacteriophage D3.

Q43544112

Molecular characterization of the O-acetyl transferase gene of converting bacteriophage SF6 that adds group antigen 6 to Shigella flexneri

Q46877129

Conservation of the N-terminus of some phage tail proteins

Q48708447

Sequence analysis of Escherichia coli O157:H7 bacteriophage PhiV10 and identification of a phage-encoded immunity protein that modifies the O157 antigen

Q50056791

Escherichia coli O157:H7

Q56336651

Protective effect of pyocin against lethal Pseudomonas aeruginosa infections in mice

Q67281832

The structure of the sialic acid-containing Escherichia coli O104 O-specific polysaccharide and its linkage to the core region in lipopolysaccharide

Q67474696

The structure of the neuraminic acid-containing capsular polysaccharide of Escherichia coli serotype K9

Q68224711

P275

Creative Commons CC0 License

Q6938433

P6216

copyrighted, dedicated to the public domain by copyright holder

Q88088423

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

Escherichia coli

Q25419

emerging pathogen

Q108429945

P304

page(s)

e33637

P577

publication date

2012-01-01

P1433

published in

PLOS One

Q564954

P1476

title

Genome sequence of E. coli O104:H4 leads to rapid development of a targeted antimicrobial agent against this emerging pathogen

P478

volume

Reverse relations

cites work (P2860)

Q40309282	A Broad-Host-Range Tailocin from Burkholderia cenocepacia.
Q35677616	A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity
Q94461933	Action of a minimal contractile bactericidal nanomachine
Q28727342	Adventures in data citation: sorghum genome data exemplifies the new gold standard
Q35961023	An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxin-producing Escherichia coli
Q30390256	Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex.
Q40295890	Bacteriophage SP6 encodes a second tailspike protein that recognizes Salmonella enterica serogroups C2 and C3.
Q58801464	Crystal Structures of R-Type Bacteriocin Sheath and Tube Proteins CD1363 and CD1364 From in the Pre-assembled State
Q46899589	Drug discovery: Leaving no stone unturned
Q57002165	Experiences in integrated data and research object publishing using GigaDB
Q41192941	F-Type Bacteriocins of Listeria monocytogenes: a New Class of Phage Tail-Like Structures Reveals Broad Parallel Coevolution between Tailed Bacteriophages and High-Molecular-Weight Bacteriocins
Q28070349	Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity
Q46163652	Genome sequences published outside of Standards in Genomic Sciences, March-April 2012.
Q40063929	New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability.
Q64083392	Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages
Q47295032	Public Health Research Resulting from One of the World's Largest Outbreaks Caused by Entero-Hemorrhagic Escherichia coli in Germany 2011: A Review.
Q30459288	Rapid clinical bacteriology and its future impact
Q27678284	Rapid countermeasure discovery against Francisella tularensis based on a metabolic network reconstruction
Q26992214	Ribosomally encoded antibacterial proteins and peptides from Pseudomonas
Q38051893	Tools from viruses: bacteriophage successes and beyond

P819	ADS bibcode	2012PLoSO...733637S
P356	DOI	10.1371/JOURNAL.PONE.0033637
P932	PMC publication ID	3303846
P698	PubMed publication ID	22432037
P5875	ResearchGate publication ID	221724607